Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Up 22.9% in April

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,073,400 shares, a growth of 22.9% from the March 31st total of 873,500 shares. Currently, 0.5% of the shares of the company are short sold. Based on an average daily volume of 300 shares, the short-interest ratio is currently 3,578.0 days.

Recordati Industria Chimica e Farmaceutica Price Performance

Shares of OTCMKTS RCDTF remained flat at $56.04 during trading hours on Tuesday. The stock has a market capitalization of $11.56 billion, a price-to-earnings ratio of 28.02 and a beta of 0.26. Recordati Industria Chimica e Farmaceutica has a 52-week low of $49.00 and a 52-week high of $56.04. The business has a 50 day simple moving average of $53.96 and a 200-day simple moving average of $53.82.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.